XBRANE BIOPHARMA AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.3405 SEK | -4.89% |
|
-13.80% | -96.60% |
| Mar. 18 | Xbrane Biopharma AB(OM:XBRANE) dropped from S&P Global BMI Index | CI |
| Feb. 26 | Transcript : Xbrane Biopharma AB, 2023 Earnings Call, Feb 26, 2024 |
Evolution of the average Target Price on Xbrane Biopharma AB
Price target over the last 5 years
History of analyst recommendation changes
ab42cd88230effd.Dljg6QiDrEDPYgLT_ma98nfb1s99Q_n1imCaeqU374s.fjmSxEPXmSK7MniWmiCEiiiJj4sVBKu2wyXyQ9xgvL9CIs2-QsGcd6UqYQ~478c92a5670c182186aa4deff07fe8fe
Analysts' Consensus
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.358
SEK
Average target price
0.75
SEK
Spread / Average Target
+109.50%
High Price Target
0.75
SEK
Spread / Highest target
+109.50%
Low Price Target
0.75
SEK
Spread / Lowest Target
+109.50%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
C+
EPS Revisions
- Stock Market
- Equities
- XBRANE Stock
- Consensus Xbrane Biopharma AB
